Kenyataan Amaran Berkaitan Dengan 'Increased Risk For Opportunistic Infections Such As Activation of Latent Viral Infections Including BK Virus - Associated Nephropathy' Yang Perlu Dimuatkan Pada Sisip Bungkusan Produk Immunosuppressant

Kadar pengguna: 1 / 5

bintang aktifBintang tidak aktifBintang tidak aktifBintang tidak aktifBintang tidak aktif
 

Date : 13 October 2009

 

Click here to view / download the circular ( 1081 KB, icon pdf )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Rabu 27 Mac 2024, 22:44:22.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search